Zhifeng Ye Junhua Guo
10.3389/fonc.2023.1082115
Front Oncol
2023 Mar 16;13:1082115.
i1171n ensartinib lorlatinib lung cancer multiple alk mutations
CC BY
https://pubmed.ncbi.nlm.nih.gov/37007089/
Case Reports
PMC10062446
37007089
Acquired ALK G1202R-, ALK I1171N-, or EML4-ALK-mediated resistance to ensartinib in lung adenocarcinoma but responded to lorlatinib: A case report
2023